Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-154-4 | CAS number: 134-72-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Ames test
The substance was tested for its mutagenic potential based on the ability to induce point mutation in several strains of Salmonella typhimurium (TA 1535, TA 100, TA98, TA 97) in a reverse mutation assay. Strains were exposed to 0, 100, 333, 1000, 3333, and 10,000 µg/plate. An increase in the number of his+ revertants was not observed in the preincubation test either without S9 mix or after the addition of a metabolizing system. It was therefore concluded that the test substance is not mutagenic under these experimental conditions.
In addition, two bacterial reverse mutation studies performed with two different structural analogues of ephedrine sulphate are available. The mutagenicity of (-)-Norephedrin S krist has been tested with4 Salmonella typhimurium strains (TA 1535, TA 1537, TA 98, and TA 100) and one E. Coli strain (WP2 uvrA) in astandard plate test and a preincubation test (BASF 2000). The mutagenicity of (+)-Pseudoephedrin-HCl has been tested with 4 Salmonella typhimurium strains (TA 1535, TA 1537, TA 98, and TA 100) in a standard plate test and a preincubation test (BASF 1991). In none of these studies an increase in the number of revertants was observed either without S9 mix or after the addition of a metabolizing system.
In the study performed with ephedrine sulphate, Salmonella typhimurium strains TA 1535, TA 100, TA 98, and TA97 were used. In accordance with OECD Guideline 471, mutagenicity in bacteria should also be tested in Salmonella typhimurium strain TA102 or E.coli WP2. In the studies performed with the two analogues of ephedrine sulfate no mutagencity was observed in the different Salmonella strains and E.coli WP2. It was therefore concluded that these test substances are not mutagenic in bacteria and as a result ephedrine sulphate is considered to be not mutagenic to bacteria.
CHO sister-chromatid exhange
The substance was tested for its mutagenic potential based on the ability to induce sister-chromatid exchanges in Chinese hamster ovary cells. Cells were exposed to 6500, 7000, 7500, and 8000 µg/mL with S9 -mix and to 1000, 1250, 1490, 1740 µg/mL without metabolic activation. Cytotoxicity was observed at the highest concentration tested for both experiments with and without metabolic activation. No increase in the number of sister-chromatid exchanges was observed with metabolic activation. An increase in the number of sister-chromatid exchanges was observed without metabolic activation. However this increase was less than two-fold and only at one dose tested and therefore this effect is considered to be a weak evidence of activity.
CHO chromosomal aberrations
The substance was tested for its mutagenic potential based on the ability to induce chromosomal aberrations in Chinese hamster ovary cells. Two chromosomal aberrations tests have been performed. In experiment 1, cells to which the metabolizing system was not added were exposed to 0, 1490, 1740, 1990, 2490, 2760, and 3000 µg/mL, and cells to which the metabolizing was added were exposed to 0, 5600, 6000, 6400, 7000, 7600, and 8000 µg/mL. In experiment 2, cells to which the metabolizing system was not added were exposed to 0, 503, 1081, and 2325 µg/mL, and cells to which the metabolizing was added were exposed to 0, 1081, 2325, and 5000 µg/mL. Only in experiment 1 in the presence of S9-mix an increase in the percentage of cells with aberrations was observed (6400 and 6400 µg/mL). However the concentrations at which the effects were observed were much higher than the recommended ones in OECD Guideline 473. Therefore it is concluded that there is no evidence of induction of chromosomal aberrations by the test substance and its metabolites in Chinese hamster ovary cells.
Short description of key information:
Three different genetic toxicity in vitro studies are available, performed with two different cell lines. According to these studies ephedrine sulphate does not induce the number of revertants and the number of chromosomal aberrations. However a weak positive response is observed in the sister-chromatid exchange assay in the absence of metabolic activation. In addition two bacterial reverse mutation studies are available, performed with two different structural analogous of ephedrine sulphate. These two structural analogues: (-)-Norephedrin S krist, and (+)-Pseudoephedrin-HCl do not induce the number of revertants either without S9 mix or after the addition of a metabolizing system.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
The bacterial reverse mutation assay with ephedrine sulphate and two structural analogues were negative. In addition a chromosome aberration assay with ephedrine sulfate showed that ephedrine sulfate is not clastogenic. However a weak positive effect has been observed in a sister chromatid exchange assay. Therefore classification for genetic toxicity is accordance with Directive 67/548/EEC (DSD) and EU Classification, Labeling and Packaging of Substances and Mixtures (CLP) Regulation No. 1272/2008 is not possible and additional data is necessary.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.